iRegene Therapeutics Co., Ltd.

Quick facts

Phase 2 pipeline

• Human Dopaminergic Progenitor Cells · Neurology
  Dopaminergic progenitor cells are thought to replace or repair dopamine-producing neurons in the brain.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• iRegene Therapeutics Co., Ltd. portfolio CI brief
• iRegene Therapeutics Co., Ltd. pipeline updates RSS